Increasing expression of heme oxygenase-1 by proteasome inhibition protects astrocytes from heme-mediated oxidative injury - PubMed (original) (raw)

Comparative Study

Increasing expression of heme oxygenase-1 by proteasome inhibition protects astrocytes from heme-mediated oxidative injury

Jing Chen et al. Curr Neurovasc Res. 2005 Jul.

Abstract

Hemin is released from hemoglobin after CNS hemorrhage, and may contribute to cell loss in surrounding tissue. Heme oxygenase-1 (HO-1) is induced by these injuries, and may have an effect on cell viability. In a prior study, we reported that increasing HO-1 expression by adenoviral gene transfer prior to hemin exposure attenuated oxidative stress and cell death in astrocytes. However, rapid gene transfer to the CNS may not be feasible. HO-1 expression is controlled by a stress-responsive transcription factor, Nrf2, which is a labile protein that is subject to proteasomal degradation. In this study, we hypothesized that preventing degradation of Nrf2 with a lipid-soluble proteasome inhibitor would increase HO-1 expression and protect astrocytes from hemin. Treatment of cortical astrocyte cultures with 1 microM MG-132 resulted in a rapid increase in Nrf2, to a level that was five-fold that of vehicle-treated cultures by 2 h. This was followed by a three to six-fold increase in HO-1 expression that persisted through the 16 h observation period. Exposure of cultures to 30 microM or 60 microM hemin for 8 h resulted in death, as measured by LDH release, of 39+/-3.0 or 67.5+/-5.9% of astrocytes. Pre-treatment with MG-132 prevented approximately half of this injury. Cytoprotection persisted at 24 h, and was also observed when injury was assessed via the MTT assay. Astrocyte protein oxidation produced by hemin was also significantly attenuated by MG-132 pre-treatment. These results suggest that increasing HO-1 expression with a proteasome inhibitor protects astrocytes from heme-mediated oxidative injury. This pharmacological approach may provide a mechanism for rapidly upregulating HO-1 in astrocytes after CNS hemorrhage.

PubMed Disclaimer

Cited by

Effect of iron chelators on methemoglobin and thrombin preconditioning.
Chen-Roetling J, Sinanan J, Regan RF. Chen-Roetling J, et al. Transl Stroke Res. 2012 Dec;3(4):452-9. doi: 10.1007/s12975-012-0195-4. Transl Stroke Res. 2012. PMID: 23585819 Free PMC article.
Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage.
Chen-Roetling J, Regan RF. Chen-Roetling J, et al. Curr Pharm Des. 2017;23(15):2226-2237. doi: 10.2174/1381612822666161027150616. Curr Pharm Des. 2017. PMID: 27799046 Free PMC article. Review.
Proteasome biology and therapeutics in cardiac diseases.
Shukla SK, Rafiq K. Shukla SK, et al. Transl Res. 2019 Mar;205:64-76. doi: 10.1016/j.trsl.2018.09.003. Epub 2018 Sep 28. Transl Res. 2019. PMID: 30342797 Free PMC article. Review.
Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury.
Cui W, Bai Y, Luo P, Miao L, Cai L. Cui W, et al. Oxid Med Cell Longev. 2013;2013:306073. doi: 10.1155/2013/306073. Epub 2013 Mar 7. Oxid Med Cell Longev. 2013. PMID: 23533688 Free PMC article. Review.
Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.
Shang F, Taylor A. Shang F, et al. Mol Aspects Med. 2012 Aug;33(4):446-66. doi: 10.1016/j.mam.2012.04.001. Epub 2012 Apr 10. Mol Aspects Med. 2012. PMID: 22521794 Free PMC article. Review.

Increasing expression of heme oxygenase-1 by proteasome inhibition protects astrocytes from heme-mediated oxidative injury - PubMed (original) (raw)